Status:
ACTIVE_NOT_RECRUITING
Three-Axis Wearable Adaptive Vestibular Stimulator
Lead Sponsor:
Mayo Clinic
Conditions:
Motion Sickness
Eligibility:
All Genders
21-55 years
Phase:
NA
Brief Summary
The purpose of this study is to improve current galvanic vestibular stimulation (GVS) technology to ease the motion sickness often associated with virtual reality (VR) simulation.
Detailed Description
The Three-Axis Wearable Adaptive Vestibular Stimulator (3WAVeS) technology that combines galvanic vestibular stimulation (GVS) and Virtual Reality (VR) will not only increase VR-based simulation reali...
Eligibility Criteria
Inclusion
- For our purposes, participants must be able to consent to participate themselves and be 21 to 55 years of age
- Must be able to attend in-person sessions at the Mayo Aerospace Medicine and Vestibular Research Laboratory in Scottsdale, AZ.
- No racial/ethnic groups will be excluded, although all participants must be fluent speakers of English.
Exclusion
- \- History of vestibular disease, migraine, or significant balance disorder; history of severe motion sensitivity, women who are pregnant.
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06106256
Start Date
November 15 2023
End Date
December 1 2025
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Arizona
Scottsdale, Arizona, United States, 85259